个人科研网厅 | | 帮助
高级检索
当前位置： 首页 > 详情页

Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005-2014

| 认领 | 导出 | |

文献详情

资源类型：
WOS体系：
Pubmed体系：

收录情况： ◇ SCIE

作者：
Hu, F-P.[1] * ; Guo, Y.[1] ; Zhu, D-M.[1] ; Wang, F.[1] ; Jiang, X-F.[2] ; Xu, Y-C.[3] ; Zhang, X-J.[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20] ; Zhang, C-X.[4] ; Ji, P.[4] ; Xie, Y.[5] ; Kang, M.[5] ; Wang, C-Q.[6] ; Wang, A-M.[6] ; Xu, Y-H.[7] ; Shen, J-L.[7] ; Sun, Z-Y.[8] ; Chen, Z-J.[8] ; Ni, Y-X.[9] ; Sun, J-Y.[9] ; Chu, Y-Z.[10] ; Tian, S-F.[10] ; Hu, Z-D.[11] ; Li, J.[11] ; Yu, Y-S.[12] ; Lin, J.[12] ; Shan, B.[13] ; Du, Y.[13] ; Han, Y.[14] ; Guo, S.[14] ; Wei, L-H.[15] ; Wu, L.[15] ; Zhang, H.[16] ; Kong, J.[16] ; Hu, Y-J.[17] ; Ai, X-M.[17] ; Zhuo, C.[18] ; Su, D-H.[18] ; Yang, Q.[19] ; Jia, B.[20] ; Huang, W.[20] ;
单位： [1]Fudan Univ, Huashan Hosp, Inst Antibiot, 12 M Wulumuqi Rd, Shanghai 200040, Peoples R China [2]Fudan Univ, Huashan Hosp, Lab Med, 12 M Wulumuqi Rd, Shanghai 200040, Peoples R China [3]Peking Union Med Coll Hosp, Lab Med, Beijing, Peoples R China [4]Xinjiang Med Univ, Teaching Hosp 1, Lab Med, Urumqi, Xinjiang, Peoples R China [5]Sichuan Univ, West China Hosp, Lab Med, Chengdu, Sichuan, Peoples R China [6]Fudan Univ, Childrens Hosp, Lab Med, 12 M Wulumuqi Rd, Shanghai 200040, Peoples R China [7]Anhui Med Univ, Affiliated Hosp 1, Lab Med, Hefei, Anhui, Peoples R China [8]Huazhong Univ Sci & Technol, Tongji Hosp, Lab Med, Huazhong, Hubei, Peoples R China [9]Shanghai Jiao Tong Univ, Ruijin Hosp, Lab Med, Shanghai 200030, Peoples R China [10]China Med Univ, Hosp 1, Lab Med, Shenyang 110001, Peoples R China [11]Tianjin Med Univ, Gen Hosp, Lab Med, Tianjin, Peoples R China [12]Zhejiang Univ, Sir Run Run Shaw Hosp, Coll Med, Lab Med, Hangzhou, Zhejiang, Peoples R China [13]Yunnan Med Univ, Affiliated Hosp 1, Lab Med, Kunming, Yunnan, Peoples R China [14]Inner Mongolia Med Univ, Affiliated Hosp 1, Lab Med, Hohhot, Inner Mongolia, Peoples R China [15]Gansu Prov Hosp, Lab Med, Lanzhou, Gansu, Peoples R China [16]Shanghai Childrens Hosp, Lab Med, Shanghai 200040, Peoples R China [17]Beijing Hosp, Lab Med, Beijing, Peoples R China [18]Guangzhou Med Univ, Affiliated Hosp 1, Lab Med, Guangzhou, Guangdong, Peoples R China [19]Zhejiang Univ, Affiliated Hosp 1, Lab Med, Hangzhou, Zhejiang, Peoples R China [20]Chongqing Med Univ, Affiliated Hosp 1, Lab Med, Chongqing, Peoples R China
出处：
DOI： 10.1016/j.cmi.2016.01.001
ISSN：

关键词： Acinetobacter baumannii antimicrobial resistance carbapenems CHINET surveillance of bacterial resistance Escherichia coli Klebsiella pneumoniae Pseudomonas aeruginosa Staphylococcus aureus

摘要：
With the aim of gathering temporal trends on bacterial epidemiology and resistance from multiple laboratories in China, the CHINET surveillance system was organized in 2005. Antimicrobial susceptibility testing was carried out according to a unified protocol using the Kirby-Bauer method or automated systems. Results were analyzed according to Clinical and Laboratory Standards Institute (CLSI) 2014 definitions. Between 2005 and 2014, the number of bacterial isolates ranged between 22 774 and 84 572 annually. Rates of extended-spectrum beta-lactamase production among Escherichia coli isolates were stable, between 51.7 and 55.8%. Resistance of E. coli and Klebsiella pneumoniae to amikacin, ciprofloxacin, piperacillin/tazobactam and cefoperazone/sulbactam decreased with time. Carbapenem resistance among K. pneumoniae isolates increased from 2.4 to 13.4%. Resistance of Pseudomonas aeruginosa strains against all of antimicrobial agents tested including imipenem and meropenem decreased with time. On the contrary, resistance of Acinetobacter baumannii strains to carbapenems increased from 31 to 66.7%. A marked decrease of methicillin resistance from 69% in 2005 to 44.6% in 2014 was observed for Staphylococcus aureus. Carbapenem resistance rates in K. pneumoniae and A. baumannii in China are high. Our results indicate the importance of bacterial surveillance studies. Clinical Microbiology and Infection (C) 2016 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.

基金：
Pfizer Investigator Initiated Research [WI207259]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81273559]

基金编号： WI207259 81273559

语种：
外文
高被引：
被引次数：
WOS：
PubmedID：
中科院(CAS)分区：
出版当年[2015]版：
大类 | 2 区 医学
小类 | 2 区 传染病学 2 区 微生物学
最新[2025]版：
大类 | 2 区 医学
小类 | 1 区 传染病学 2 区 微生物学
JCR分区：
出版当年[2014]版：
Q1 INFECTIOUS DISEASES Q1 MICROBIOLOGY
最新[2023]版：
Q1 INFECTIOUS DISEASES Q1 MICROBIOLOGY

影响因子： 最新[2023版] 最新五年平均 出版当年[2014版] 出版当年五年平均 出版前一年[2013版] 出版后一年[2015版]

第一作者：
第一作者单位： [1]Fudan Univ, Huashan Hosp, Inst Antibiot, 12 M Wulumuqi Rd, Shanghai 200040, Peoples R China
通讯作者：
通讯机构： [1]Fudan Univ, Huashan Hosp, Inst Antibiot, 12 M Wulumuqi Rd, Shanghai 200040, Peoples R China
推荐引用方式(GB/T 7714)：
Hu F-P.,Guo Y.,Zhu D-M.,et al.Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005-2014[J].CLINICAL MICROBIOLOGY AND INFECTION.2016,22:S9-S14.doi:10.1016/j.cmi.2016.01.001.
APA：
Hu, F-P.,Guo, Y.,Zhu, D-M.,Wang, F.,Jiang, X-F....&Huang, W..(2016).Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005-2014.CLINICAL MICROBIOLOGY AND INFECTION,22,
MLA：
Hu, F-P.,et al."Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005-2014".CLINICAL MICROBIOLOGY AND INFECTION 22.(2016):S9-S14

相关文献

[1]Appropriateness of Empirical Fluoroquinolones Therapy in Patients Infected with Escherichia coli, Klebsiella pneumoniae, or Pseudomonas aeruginosa: The Importance of the CLSI Breakpoints Revision [2]Establishment of epidemiological cut-off values for cefoselis, a new fourth-generation cephalosporin, against Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, Proteus mirabilis and Pseudomonas aeruginosa. [3]Update of incidence and antimicrobial susceptibility trends of Escherichia coli and Klebsiella pneumoniae isolates from Chinese intra-abdominal infection patients [4]Emergence of Ceftazidime- and Avibactam-Resistant Klebsiella pneumoniae Carbapenemase-Producing Pseudomonas aeruginosa in China. [5]Emergence of Ceftazidime- and Avibactam-Resistant Klebsiella pneumoniae Carbapenemase-Producing Pseudomonas aeruginosa in China [6]r2010年中国CHINET临床分离自无菌体液的细菌分布和耐药性监测 [7]2012年中国CHINET细菌耐药性监测 [8]Isolation and determination of four potential antimicrobial components from Pseudomonas aeruginosa extracts [9]2012年中国CHINET铜绿假单胞菌耐药性监测 [10]2012年中国CHINET无菌体液中分离的细菌构成和耐药性监测

资源点击量：426 今日访问量：0 总访问量：410 更新日期：2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有：重庆聚合科技有限公司 渝ICP备12007440号-3 地址：重庆市两江新区泰山大道西段8号坤恩国际商务中心16层（401121）